Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
CALL
Chubb
CB
$132B
| $13.8M | 0.01% |
109,600
-55,800
| -34% | -$7.08M |
|
1277
PUT
Emerson Electric
EMR
$86.4B
| $13.8M | 0.01% |
252,500
+9,900
| +4% | +$531K |
|
1278
CALL
HSBC
HSBC
$358B
| $13.8M | 0.01% |
405,050
-325,053
| -45% | -$10.2M |
|
1279
PUT
State Street SPDR S&P Homebuilders ETF
XHB
$1.41B
| $13.7M | 0.01% |
404,800
+66,800
| +20% | +$2.36M |
|
1280
PUT
Hasbro
HAS
$13.6B
| $13.7M | 0.01% |
172,900
+31,800
| +23% | +$2.58M |
|
1281
CALL
VeriSign
VRSN
$26.6B
| $13.7M | 0.01% |
175,000
+88,000
| +101% | +$7.06M |
|
1282
PUT
Acadia Healthcare
ACHC
$2.78B
| $13.7M | 0.01% |
276,000
+168,200
| +156% | +$8.76M |
|
1283
PUT
Coca-Cola Europacific Partners
CCEP
$48.5B
| $13.7M | 0.01% |
342,600
-75,000
| -18% | -$2.86M |
|
|
NBIS
1284
PUT
Nebius Group N.V.
NBIS
$60.3B
| $13.7M | 0.01% |
648,500
-27,700
| -4% | -$603K |
|
1285
CALL
Fluor
FLR
$6.86B
| $13.6M | 0.01% |
265,600
+15,000
| +6% | +$774K |
|
|
EGRX
1286
CALL
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $13.6M | 0.01% |
194,700
+115,400
| +146% | +$6.39M |
|
1287
SBA Communications
SBAC
$19.9B
| $13.6M | 0.01% |
121,034
+107,016
| +763% | +$12.1M |
|
1288
CALL
J.M. Smucker
SJM
$13.4B
| $13.6M | 0.01% |
100,000
-61,400
| -38% | -$9.01M |
|
1289
CALL
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $13.5M | 0.01% |
435,000
+249,000
| +134% | +$7.7M |
|
1290
CALL
Omnicom Group
OMC
$24.2B
| $13.4M | 0.01% |
158,000
-36,300
| -19% | -$3.04M |
|
1291
PUT
Nucor
NUE
$56.2B
| $13.4M | 0.01% |
271,200
-30,200
| -10% | -$1.54M |
|
1292
PUT
A.O. Smith
AOS
$8.45B
| $13.4M | 0.01% |
271,400
+96,200
| +55% | +$4.49M |
|
1293
CALL
Hecla Mining
HL
$14.1B
| $13.4M | 0.01% |
2,342,600
+128,500
| +6% | +$786K |
|
1294
CALL
Archer Daniels Midland
ADM
$38.2B
| $13.3M | 0.01% |
316,200
-149,300
| -32% | -$6.46M |
|
1295
CALL
Steel Dynamics
STLD
$33.1B
| $13.3M | 0.01% |
533,100
-118,600
| -18% | -$3.03M |
|
|
IM
1296
DELISTED
Ingram Micro
IM
| $13.3M | 0.01% |
373,513
+22,900
| +7% | +$795K |
|
1297
CALL
NRG Energy
NRG
$23.9B
| $13.3M | 0.01% |
1,185,100
+874,500
| +282% | +$11.4M |
|
1298
CALL
Golar LNG
GLNG
$5.31B
| $13.3M | 0.01% |
626,200
+8,200
| +1% | +$157K |
|
|
CBPO
1299
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $13.3M | 0.01% |
106,620
+26,465
| +33% | +$3.12M |
|
1300
PUT
Zillow
ZG
$8.34B
| $13.2M | 0.01% |
384,200
-189,800
| -33% | -$6.8M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.